Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey
A global qualitative analysis of open‑ended responses from 1,630 ayahuasca drinkers identified three core aspects of post‑ceremony integration—overall appraisal (easy, challenging, ongoing), beneficial tools (community, somatic practices, journaling), and integration challenges (disconnection, reverting to old life)—and found integration is often lengthy and difficult yet can promote growth. The authors argue this challenges psychotherapy‑centred models of psychedelic aftercare and propose an expanded definition of integration that emphasises communal and somatic approaches alongside working through adjustment challenges.
Authors
- Luiz Tófoli
- Daniel Perkins
- Joseph Sarris
Published
Abstract
Ayahuasca is an Amazonian psychoactive plant medicine being explored for its potential therapeutic uses in Western contexts. Preliminary studies link ayahuasca use with improvements across a range of mental health indicators, but studies have not yet explored qualitative aspects of the post-treatment process known in the psychedelic literature as “integration”. This includes how participants make sense of their ayahuasca experiences and minimise harm/maximise benefits after ayahuasca use. A global online survey, conducted between 2017 and 2019, collected responses from 1630 ayahuasca drinkers (50.4% male, mean age = 43 years) to an open-ended question about their integration experiences after consuming ayahuasca. Inductive codebook thematic analysis was used to identify themes in participants’ integration experiences. Participants described integration experiences in three main ways. First, was an overall appraisal of the integration experience (e.g., as easy, challenging, or long-term/ongoing). Second, was describing beneficial tools which facilitated integration (e.g., connecting with a like-minded community and ongoing practice of yoga, meditation, journaling, etc.). Third, was describing integration challenges (e.g., feeling disconnected, going back to “old life” with new understandings, etc.). These findings suggest that integrating ayahuasca experiences can be challenging and take considerable time, though working through integration challenges may facilitate positive growth. Findings also challenge the role of individual psychotherapy as the primary integration tool in Western psychedelic therapy, suggesting that communal and somatic elements may also be useful. An expanded definition of psychedelic integration is proposed which includes working with integration challenges and adjusting to life changes.
Research Summary of 'Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey'
Introduction
Ayahuasca is an Amazonian psychoactive brew containing beta-carbolines (Banisteriopsis caapi) and DMT-containing leaves (Psychotria viridis or Diplopterys cabrerana) that has attracted growing Western therapeutic and spiritual interest. The ingestion of ayahuasca produces variable altered states—often including intense vomiting, vivid visions, encounters with perceived nonself entities and autobiographical reprocessing—that participants sometimes describe as among the most meaningful of their lives but which can also precipitate challenging psychological material. While prior quantitative work links ayahuasca with improvements in conditions such as depression and substance use, the post-acute process of psychedelic integration—how people make sense of and apply their experiences, and how they manage harms and benefits—has been little explored in qualitative depth, especially across diverse, non-clinical contexts. Dinis-Oliveira and colleagues set out to address this gap by analysing open-ended responses about integration from a large, global sample of ayahuasca drinkers drawn from the Global Ayahuasca Project. The study aimed to characterise how participants conceptualise integration, what supports and challenges they encounter, and to propose an updated, participant-informed definition of psychedelic integration. This sub-study offers a preliminary, qualitative mapping of integration experiences across contexts such as syncretic churches, retreats and neo‑shamanic ceremonies, with potential implications for harm reduction and support models as ayahuasca use increases internationally.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Cowley-Court, T., Chenhall, R., Sarris, J., Bouso, J. C., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2023). Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey. Psychoactives, 2(2), 201-221. https://doi.org/10.3390/psychoactives2020014
References (21)
Papers cited by this study that are also in Blossom
Bouso, J. C., Andión, O., Sarris, J. et al. · PLOS Global Public Health (2022)
Riba, J., Rodríguez-Fornells, A., Barbanoj, M. J. · Psychopharmacology (2002)
Argento, E., Capler, R., Thomas, G. et al. · Drug and Alcohol Review (2019)
Lafrance, A., Loizaga-Velder, A., Fletcher, J. et al. · Journal of Psychoactive Drugs (2017)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Ramaekers, J. G. · Psychopharmacology (2022)
Ruffell, S. G. D., Netzband, N., Tsang, W. et al. · Frontiers in Psychiatry (2021)
Fábregas, J. M., González, D., Fondevila, S. et al. · Drug and Alcohol Dependence (2010)
Thomas, G., Lucas, P., Rielle Capler, N. et al. · Current Drug Abuse Reviews (2013)
Perkins, D., Opaleye, E. S., Simonová, H. et al. · Drug and Alcohol Review (2021)
Show all 21 referencesShow fewer
Renelli, M., Fletcher, J., Tupper, K. W. et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2018)
Perkins, D., Schubert, V., Simonová, H. et al. · Frontiers in Pharmacology (2021)
Lutkajtis, A., Evans, J. · Journal of Psychedelic Studies (2023)
Talin, P., Sanabria, E. · International Journal of Drug Policy (2017)
Earleywine, M., Low, F., Lau, C. et al. · Journal of Humanistic Psychology (2022)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Psychopharmacology (2017)
Forstmann, M., Kettner, H. S., Sagioglou, C. et al. · Journal of Psychopharmacology (2023)
Perkins, D., Ruffell, S. G. D., day, K. et al. · Frontiers in Neuroscience (2023)
Bathje, G. J., Fenton, J., Pillersdorf, D. et al. · Journal of Humanistic Psychology (2021)
Cited By (2)
Papers in Blossom that reference this study
Robinson, O., Evans, J., Luke, D. et al. · Frontiers in Psychology (2024)
Argyri, E. K., Evans, J., Luke, D. et al. · SSRN (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.